or Try an Advanced Search...

    Novavax Stocks List

    Symbol Grade Name % Change
    NVAX F Novavax, Inc. -4.82
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Clinical Development Coronavirus Infectious Diseases Influenza Influenza Vaccine Medicine Rabies Seasonal Influenza Vaccination Vaccines

    Related ETFs - A few ETFs which own one or more of the above listed Novavax stocks.

    Symbol Grade Name Weight
    GERM F ETFMG Treatments Testing and Advancements ETF 1.45
    XBI D SPDR S&P Biotech ETF 0.82
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 0.62
    LABU F Direxion Daily S&P Biotech Bull 3X Shares 0.6
    TINY D ProShares Nanotechnology ETF 0.6
    View all Novavax ETFs...
    Compare ETFs
    Compare BBC to TINY Compare XBI to BBC Compare XBI to LABU

        Novavax Stocks Recent News

        Date Stock Title
        Apr 22 NVAX How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
        Apr 21 NVAX These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
        Apr 19 NVAX 12 Most Shorted Stocks in 2024
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Clinical Development Coronavirus Infectious Diseases Influenza Influenza Vaccine Medicine Rabies Seasonal Influenza Vaccination Vaccines
        Novavax

        Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.

        More about Novavax
        Browse All Tags